Windlas Biotech will hold a board meeting on April 17, 2026 to consider and approve a buyback of its fully paid-up equity shares.
The trading window for designated persons remains closed from April 1, 2026 until 48 hours after FY2026 results become public.
This intimation is made under Regulation 29 of SEBI Listing Obligations and Disclosure Requirements.